NASDAQ: DRIO - DarioHealth Corp.

Yield per half year: -41.1%
Dividend yield: 0.00%
Sector: Healthcare

Share chart DarioHealth Corp.

Extended chart Simple chart
Financial Markets by TradingView

About DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system.

more details
It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2014-10-06
ISIN US23725P2092
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.dariohealth.com
Цена ао 1.52
Change price per day: +0.2307% (0.6934)
Change price per week: -13.13% (0.8)
Change price per month: -3.5% (0.7202)
Change price per 3 month: -34.74% (1.065)
Change price per half year: -41.1% (1.18)
Change price per year: -59.59% (1.72)
Change price per 3 year: -94.72% (13.16)
Change price per 5 year: -82.18% (3.9)
Change price per 10 year: 0% (0.695)
Change price per year to date: -16.25% (0.8299)
All parameters

Underestimation

Title Value Grade
P/S 2.33 6
P/BV 0.8149 9
P/E 0 0
EV/EBITDA -0.7835 0
Total: 5.63

Efficiency

Title Value Grade
ROA, % -56.92 0
ROE, % -94.35 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.5637 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 167.79 10
Yield Ebitda, % 210.73 10
Yield EPS, % -73.28 0
Total: 7.8
More

Institutions Volume Share, %
Nantahala Capital Management, LLC 4673506 15.87
Appian Way Asset Management LP 1322444 4.49
Y.D. More Investments Ltd 1288518 4.38
Phoenix Holdings Ltd. 1180813 4.01
Clal Insurance Enterprises Holdings Ltd 875964 2.98
Vanguard Group Inc 363042 1.23
Geode Capital Management, LLC 270573 0.92
Clarity Capital Partners LLC 170426 0.58
Blackrock Inc. 112619 0.38
LPL Financial LLC 109901 0.37

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00664 17.09 1.54048



Head Job title Payment Year of birth
Mr. Erez Raphael CEO & Director 722.19k 1973 (52 years)
Dov Oppenheim Co-Founder & Production Chief N/A
Josh Fischer Senior Vice President of Operations & Compliance N/A
Claudia Levi Content & Communications Manager N/A
Mr. Jean Christophe Muyl Head of Commercialization North America N/A
Mr. Tomer Ben-Kiki Chief Technology Officer N/A 1971 (54 years)
Limor Drezner Chief People Officer N/A
Mr. Zvi Ben David CPA CFO, Treasurer & Secretary 342.58k 1961 (64 years)
Kat Parrella Investor Relations Manager
Ms. Mona Dean Chief Compliance Officer

Address: United States, New York. NY, 18 West 18th Street - open in Google maps, open in Yandex maps
Website: https://www.dariohealth.com